EGFR exon 19 insertions show good response to gefitinib, but short time to progression in Japanese patients.

Subjects

Subjects :

Adenocarcinoma genetics
Adenocarcinoma pathology
Aged
Bone Neoplasms genetics
Bone Neoplasms secondary
ErbB Receptors antagonists & inhibitors
Female
Gefitinib
Humans
Lung Neoplasms genetics
Lung Neoplasms pathology
Male
Middle Aged
Protein Kinase Inhibitors therapeutic use
Adenocarcinoma drug therapy
Bone Neoplasms drug therapy
ErbB Receptors genetics
Exons genetics
Lung Neoplasms drug therapy
Quinazolines therapeutic use

Details

Language :

English

ISSN :

1556-1380

Volume :

9

Issue :

2

Database :

MEDLINE

Journal :

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Publication Type :

Academic Journal

Accession number :

24419426

Full Text :

https://doi.org/10.1097/JTO.0b013e3182a735cc